259 filings
8-K
DXR
Daxor Corp.
25 Mar 24
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
2:00pm
N-CSR/A
DXR
Daxor Corp.
19 Mar 24
Certified annual shareholder report (management investment company) (amended)
5:23pm
N-CEN
DXR
Daxor Corp.
15 Mar 24
Annual report (registered investment company)
5:26pm
N-CSR
DXR
Daxor Corp.
15 Mar 24
Certified annual shareholder report (management investment company)
4:54pm
NT-NCSR/A
DXR
Daxor Corp.
8 Mar 24
Notice of inability to timely file Form N-CSR (amended)
1:49pm
NT-NCSR/A
fz341k xz4l
29 Feb 24
Notice of inability to timely file Form N-CSR (amended)
5:28pm
NT-NCSR
zo32vh3ojmlyxp3 dkve
29 Feb 24
Notice of inability to timely file Form N-CSR
4:15pm
CORRESP
pq7ghwg9cnsgcpwwq37o
14 Feb 24
Correspondence with SEC
12:00am
8-K
22oz4aexwm94
2 Jan 24
Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer
8:52am
8-K
qosbk
27 Nov 23
Other Events
9:12pm
8-K
6g843
27 Oct 23
Other Events
5:27pm
N-CSRS
2zzk1 zj6sv
28 Aug 23
Certified semi-annual shareholder report (management investment company)
4:01pm
N-PX
uj46e9f82
15 Aug 23
Annual report of proxy voting record
7:14am
8-K
4ttgr51cr6d1w9k6x
13 Jul 23
Submission of Matters to a Vote of Security Holders
4:27pm
8-K
s512b8093uey 7ef
25 May 23
Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering
7:04pm
N-CEN
pdwqod6
16 Mar 23
Annual report (registered investment company)
4:35pm
N-CSR
52ah0is1gw gt
1 Mar 23
Certified annual shareholder report (management investment company)
5:11pm
8-K
qkc8c p0voxsnn9do
21 Nov 22
Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option
8:12am
N-CSR/A
x6mz ewy7qgp2c4b
14 Nov 22
Certified annual shareholder report (management investment company) (amended)
4:25pm